BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 8093499)

  • 1. Creutzfeldt-Jakob disease and blood transfusion.
    Esmonde TF; Will RG; Slattery JM; Knight R; Harries-Jones R; de Silva R; Matthews WB
    Lancet; 1993 Jan; 341(8839):205-7. PubMed ID: 8093499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.
    Hewitt PE; Llewelyn CA; Mackenzie J; Will RG
    Vox Sang; 2006 Oct; 91(3):221-30. PubMed ID: 16958834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.
    Llewelyn CA; Hewitt PE; Knight RS; Amar K; Cousens S; Mackenzie J; Will RG
    Lancet; 2004 Feb; 363(9407):417-21. PubMed ID: 14962520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of evidence of transfusion transmission risk of Creutzfeldt-Jakob disease in the United States: Results froma 28-year lookback study.
    Crowder LA; Dodd RY; Schonberger LB
    Transfusion; 2024 Jun; 64(6):980-985. PubMed ID: 38650381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creutzfeldt-Jakob disease lookback study: 21 years of surveillance for transfusion transmission risk.
    Crowder LA; Schonberger LB; Dodd RY; Steele WR
    Transfusion; 2017 Aug; 57(8):1875-1878. PubMed ID: 28444687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study.
    Urwin PJ; Mackenzie JM; Llewelyn CA; Will RG; Hewitt PE
    Vox Sang; 2016 May; 110(4):310-6. PubMed ID: 26709606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study.
    Dorsey K; Zou S; Schonberger LB; Sullivan M; Kessler D; Notari E; Fang CT; Dodd RY
    Transfusion; 2009 May; 49(5):977-84. PubMed ID: 19170987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographical distribution of cases of Creutzfeldt-Jakob disease in England and Wales 1970-84.
    Cousens SN; Harries-Jones R; Knight R; Will RG; Smith PG; Matthews WB
    J Neurol Neurosurg Psychiatry; 1990 Jun; 53(6):459-65. PubMed ID: 2199610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of transmission of Creutzfeldt-Jakob disease by transfusion of blood, plasma, and plasma derivatives.
    Vamvakas EC
    J Clin Apher; 1999; 14(3):135-43. PubMed ID: 10540369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant CJD and blood transfusion: are there additional cases?
    Davidson LR; Llewelyn CA; Mackenzie JM; Hewitt PE; Will RG
    Vox Sang; 2014 Oct; 107(3):220-5. PubMed ID: 24916465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases.
    Puopolo M; Ladogana A; Vetrugno V; Pocchiari M
    Transfusion; 2011 Jul; 51(7):1556-66. PubMed ID: 21214582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood transfusion and spread of variant Creutzfeldt-Jakob disease.
    Dietz K; Raddatz G; Wallis J; Müller N; Zerr I; Duerr HP; Lefèvre H; Seifried E; Löwer J
    Emerg Infect Dis; 2007 Jan; 13(1):89-96. PubMed ID: 17370520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New case of transfusion-associated vCJD in the United Kingdom.
    Euro Surveill; 2006 Feb; 11(2):E060209.2. PubMed ID: 16804207
    [No Abstract]   [Full Text] [Related]  

  • 14. Ten-year follow-up of two cohorts with an increased risk of variant CJD: donors to individuals who later developed variant CJD and other recipients of these at-risk donors.
    Checchi M; Hewitt PE; Bennett P; Ward HJ; Will RG; Mackenzie JM; Sinka K
    Vox Sang; 2016 Nov; 111(4):325-332. PubMed ID: 27432362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence of transfusion transmitted sporadic Creutzfeldt-Jakob disease: results from a bi-national cohort study.
    Holmqvist J; Wikman A; Pedersen OBV; Nielsen KR; Rostgaard K; Hjalgrim H; Edgren G
    Transfusion; 2020 Apr; 60(4):694-697. PubMed ID: 32187687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study.
    Collins S; Law MG; Fletcher A; Boyd A; Kaldor J; Masters CL
    Lancet; 1999 Feb; 353(9154):693-7. PubMed ID: 10073510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide.
    Brandel JP; Peckeu L; Haïk S
    Transfus Clin Biol; 2013 Sep; 20(4):395-7. PubMed ID: 23587616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creutzfeldt-Jakob disease and blood transfusion.
    Heye N; Hensen S; Müller N
    Lancet; 1994 Jan; 343(8892):298-9. PubMed ID: 7905126
    [No Abstract]   [Full Text] [Related]  

  • 19. Creutzfeldt-Jakob disease: current U.S. policy to further reduce the possible risk of transmission by transfusion.
    Menache D; O'Malley JP
    Biologicals; 1996 Sep; 24(3):277-83. PubMed ID: 8978926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological surveillance of Creutzfeldt-Jakob disease in the United Kingdom.
    Will RG
    Eur J Epidemiol; 1991 Sep; 7(5):460-5. PubMed ID: 1761103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.